FDA Approves Tixel’s Non-Invasive Skin Resurfacing Technology to Treat Periorbital Wrinkles

Basic foods:

• Tixel works by delivering short bursts of heat energy to the surface of the skin without damaging the deeper tissues.
• Recovery is a fraction of the time compared to laser.

The FDA has approved Tixel, an innovative non-invasive skin resurfacing technology, for the treatment of periorbital wrinkles, Sentient announced in a press release.

According to Sentient, periorbital wrinkles — the fine lines around and under the eyes commonly known as “crow’s feet” — are one of the earliest and most difficult signs of aging to treat because the skin around the eyes it is thinner and thinner. from the surrounding facial skin.

“FDA approval for the treatment of periorbital wrinkles with Tixel by Sentient is a game-changer for patients and the cosmetic industry.” Chris Sela, CEO of Sentient, said in the announcement. “It reaffirms Sentient’s commitment to innovation and delivering safe and effective outcomes for our patients.”

Tixel works by delivering short bursts of heat energy to the skin’s surface without causing damage to deeper tissues, according to the release. Combining the heat and forward motion of a medical-grade titanium tip, the device delivers thermal energy through a brief application directly to the upper layers of the skin. This transfer creates controlled micro-damage that stimulates collagen production and corrects wrinkles.

Tixel does not emit radiation and therefore does not require the eye shields commonly used during laser treatments. Pain and social downtime after treatment is minimal compared to treatments using lasers and radiofrequency, according to the release. Make-up can also be used the day after the treatment.

Since 2011, Tixel has been used in Europe and the technology was first cleared by the FDA 2 years ago for skin regeneration of all skin types.

Published by: